Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by cashascarson Sep 23, 2017 12:48pm
351 Views
Post# 26734505

TLT for beginners 101

TLT for beginners 101
In order to grow and spread so aggressively, cancer cells consume and require much greater amounts of many nutrients. In particular, cancer cells need 10 to 15 times the amount of iron as a normal, healthy cell. TLD-1433 combines inside the body with transferrin. Transferrin is a naturally occurring glyco-protein that transports iron to every cell in the body.

Cancer cell receptors greedily absorb this transferrin + TLD-1433, fooled into thinking that they are absorbing iron and hold onto it for longer periods of time, while healthy cells reject the TLD-1433 PDC quite quickly. The Trojan Horse is now inside the castle. Then what?

To be a cancer-killing Trojan Horse, able to destroy cancer cells from the inside requires two chemical-biological properties: the ability to slip past the tough cell walls of cancer cells plus the capacity to do damage once inside. This leads back to laser light.

Once the TLD-1433 has been given time to penetrate these cancer cells it’s time for the actual laser therapy – and the cancer-killing begins. When laser light targets cancer-diseased tissue with TLD-1433 inside, a photo-chemical reaction takes place.

Using laser light with the correct wavelength (i.e. colour) causes TLD-1433 to begin to generate a form of oxygen. But this form of oxygen isn’t the nourishing element essential to life. What TLD-1433 is able to produce is a form of “cytotoxic” (cell killing) oxygen known as Reactive Oxygen Species (ROS).

These ROS molecules are like tiny cancer-bombs. TLD-1433 generates enough of these ROS cancer-bombs to destroy cancer cells from the inside, with enormous success. Laboratory results indicate the destruction of more than 99% of cancer cells from Theralase’s PDT technology, with virtually no damage to surrounding tissue.

Read more at https://www.stockhouse.com/news/newswire/2017/04/12/is-trojan-horse-key-to-curing-cancer#bmv3fLjo14J4mRHt.99
Bullboard Posts